TTR and amyloidosis: Currently there is no specific licensed treatment for ATTRwt amyloidosis, but new drugs are on the horizon, with several clinical trials currently recruiting patients with transthyretin amyloidosis (http://clinicaltrials.gov/ct2/results?term=transthyretin).